Health Condition 1: 8- Other Procedures
Conditions
Interventions
Intervention1: Nil: Not Appliable
Control Intervention1: NIl: Not Applicable
Sponsors
Torrent Pharmaceuticals Ltd.
Eligibility
Inclusion criteria
Inclusion criteria: 1. Male or female patients 18 years or above 2. Clinical cases of soft tissue, traumatic or sports injuries 3. Patients willing for follow-up at scheduled visit as per protocol at same center.
Exclusion criteria
Exclusion criteria: Hypersensitivity to trypsin-chymotrypsin or paracetamol or Aceclofenac or any of the other constituents. 2. Patients treated with gabapentanoids (pregabalin, gabapentin) for neuropathic pain 3. Severe liver problems, kidney impairment, peptic ulcer, high vitreous pressure Active, or history of recurrent peptic ulcer/haemorrhage (two or more distinct episodes of proven ulceration or bleeding) 5. Hypersensitivity reactions (eg. Asthma, rhinitis, angioedema or urticaria) in response to ibuprofen, aspirin, or other non-steroidal anti-inflammatory drugs 6. Established congestive heart failure (NYHA II-IV), ischaemic heart disease, peripheral arterial disease and/or cerebrovascular disease. 7. History of gastrointestinal bleeding or perforation, related to previous NSAIDS therapy. 8. Active bleedings or bleeding disorders.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Mean change in visual analogue scale at the end of the treatmentTimepoint: at 1 week | — |
Secondary
| Measure | Time frame |
|---|---|
| Patient and physician Global impression at the end of the treatmentTimepoint: at 1 week | — |
Countries
India
Contacts
Public ContactDr Krishnaprasad K MD
Torrent Pharmaceuticals Ltd.
Outcome results
None listed